CARVOLIX SA (AFME.PA) Stock Price & Overview
EPA:AFME • FR0013333077
Current stock price
The current stock price of AFME.PA is 2.81 EUR. Today AFME.PA is up by 42.64%. In the past month the price increased by 47.89%. In the past year, price increased by 110.49%.
AFME.PA Key Statistics
- Market Cap
- 110.574M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.38
- Dividend Yield
- N/A
AFME.PA Stock Performance
AFME.PA Stock Chart
AFME.PA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to AFME.PA. When comparing the yearly performance of all stocks, AFME.PA is one of the better performing stocks in the market, outperforming 98.63% of all stocks.
AFME.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AFME.PA. AFME.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
AFME.PA Earnings
AFME.PA Forecast & Estimates
9 analysts have analysed AFME.PA and the average price target is 3.33 EUR. This implies a price increase of 18.58% is expected in the next year compared to the current price of 2.81.
AFME.PA Groups
Sector & Classification
AFME.PA Financial Highlights
Over the last trailing twelve months AFME.PA reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 29.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.64% | ||
| ROE | -69.84% | ||
| Debt/Equity | 1 |
AFME.PA Ownership
AFME.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 25.86 | 92.218B | ||
| 1EL | ESSILORLUXOTTICA | 24.73 | 92.079B | ||
| EL | ESSILORLUXOTTICA | 25.74 | 92.056B | ||
| CVX | CARVOLIX SA | N/A | 190.753M | ||
| GBT | GUERBET | N/A | 118.816M | ||
| ALCJ | CROSSJECT | 5.56 | 105.949M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 46.128M | ||
| IVN | IVISION TECH SPA | N/A | 13.684M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About AFME.PA
Company Profile
Affluent Medical SA provides treatments for serious and widespread diseases. The company is headquartered in Aix-En-Provence, Paca and currently employs 69 full-time employees. The company went IPO on 2021-06-14. The company designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. The company provides several products such as Kalios, Epygon, Artus. The company helps in treating heart disease and urinary incontinence. The firm provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.
Company Info
IPO: 2021-06-14
CARVOLIX SA
320 avenue Archimede, Les pleiades III Batiment B
Aix-en-Provence PACA FR
Employees: 66
Phone: 33442951220
CARVOLIX SA / AFME.PA FAQ
What does CARVOLIX SA do?
Affluent Medical SA provides treatments for serious and widespread diseases. The company is headquartered in Aix-En-Provence, Paca and currently employs 69 full-time employees. The company went IPO on 2021-06-14. The company designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. The company provides several products such as Kalios, Epygon, Artus. The company helps in treating heart disease and urinary incontinence. The firm provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.
What is the current price of AFME stock?
The current stock price of AFME.PA is 2.81 EUR. The price increased by 42.64% in the last trading session.
Does CARVOLIX SA pay dividends?
AFME.PA does not pay a dividend.
How is the ChartMill rating for CARVOLIX SA?
AFME.PA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of CARVOLIX SA (AFME.PA) based on its PE ratio?
CARVOLIX SA (AFME.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.38).
Can you provide the market cap for CARVOLIX SA?
CARVOLIX SA (AFME.PA) has a market capitalization of 110.57M EUR. This makes AFME.PA a Micro Cap stock.